Search research articles
Contact Us
Filters
Showing results (71-80 of 96) with videos related to
Page
of 10
Sort By:
BMC Medical Genomics
|
February 1, 2014
Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer
Devin C Koestler, Prabhakar Chalise, Mine S Cicek, et al.
International Journal of Molecular Sciences
|
October 31, 2020
The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression
Cristabelle De Souza, Jill A Madden, Dennis Minn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2015
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples
Boris Winterhoff, Luisa Freyer, Edward Hammond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma
Enrico P Spugnini, Irene Cardillo, Alessandra Verdina, et al.
Journal of the National Cancer Institute
|
February 8, 2021
Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer
Cristabelle De Souza, Jill Madden, Devin C Koestler, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Role of drug induced nuclear CTSL (nCTSL) in DNA damage response in cancer- therapeutic implications
Prabhu Thirsangu, Ling Jin, Upasana Ray, et al.
The Journal of Clinical Investigation
|
June 13, 2006
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity
Jeremy Chien, Giovanni Aletti, Alfonso Baldi, et al.
Molecular Oncology
|
May 29, 2016
Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors
Lei Zhang, Maria B Hapon, Alicia A Goyeneche, et al.
Pharmacogenomics
|
August 7, 2008
The serine protease HtrA1 is a novel prognostic factor for human mesothelioma
Alfonso Baldi, Marcella Mottolese, Bruno Vincenzi, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
November 4, 2016
Complete Transcriptome RNA-Seq
David F B Miller, Pearlly Yan, Fang Fang, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 96) with videos related to
Sort By:
Page
of 10
BMC Medical Genomics
|
February 1, 2014
Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer
Devin C Koestler, Prabhakar Chalise, Mine S Cicek, et al.
International Journal of Molecular Sciences
|
October 31, 2020
The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression
Cristabelle De Souza, Jill A Madden, Dennis Minn, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 11, 2015
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples
Boris Winterhoff, Luisa Freyer, Edward Hammond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma
Enrico P Spugnini, Irene Cardillo, Alessandra Verdina, et al.
Journal of the National Cancer Institute
|
February 8, 2021
Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer
Cristabelle De Souza, Jill Madden, Devin C Koestler, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Role of drug induced nuclear CTSL (nCTSL) in DNA damage response in cancer- therapeutic implications
Prabhu Thirsangu, Ling Jin, Upasana Ray, et al.
The Journal of Clinical Investigation
|
June 13, 2006
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity
Jeremy Chien, Giovanni Aletti, Alfonso Baldi, et al.
Molecular Oncology
|
May 29, 2016
Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors
Lei Zhang, Maria B Hapon, Alicia A Goyeneche, et al.
Pharmacogenomics
|
August 7, 2008
The serine protease HtrA1 is a novel prognostic factor for human mesothelioma
Alfonso Baldi, Marcella Mottolese, Bruno Vincenzi, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
November 4, 2016
Complete Transcriptome RNA-Seq
David F B Miller, Pearlly Yan, Fang Fang, et al.
Page
of 10